A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma

NCT00431912 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Valerio Therapeutics